Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences.

Tech stocks are bouncing back Monday after last week's selloff, which was fueled by growing investor concerns over massive AI infrastructure spending. Several big-name tech stocks are sitting out the ...

Live webcasts and recordings of these presentations will be available, as permitted by the event host, in the Events and Presentations section of Olema’s investor relations website at ir.olema.com.

Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...

The Recapitalization eliminates approximately $96 million of annual cash interest on the Senior Notes Substantial new capital and liquidity: $400 million of new money through a rights offering of new ...

STEINHAUSEN, Switzerland, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Transocean Ltd. (NYSE: RIG) today issued a quarterly Fleet Status Report that provides the current activity and contractual status of the ...

USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), today announced that it will release financial results for the quarterly period ended September 30, 2026, after U.S. markets close on Monday, ...

Ethos (Nasdaq: LIFE), a leading life insurance technology company on a mission to democratize access to life insurance, today announced its financial results for the third quarter ended September 30, ...

Xcel Energy Inc. (NASDAQ: XEL) (“Xcel Energy”) today announced that it intends to offer, subject to market and other conditions, $2,000,000,000 aggregate principal amount of convertible senior notes ...

Loews Corporation (NYSE:L) shares advanced 3.8% on Monday after the diversified holding company reported third-quarter 2026 earnings above analyst expectations, despite a decline in net income driven ...

MARA's bottom line is dominated by mark-to-market swings on its Bitcoin holdings, which drove most of last quarter's $611.3 ...

Supported The Michael J Fox Foundation for Parkinson's Research, Alzheimer's Research UK and LifeArc, the study targets earlier detection, prevention and treatment of Parkinson’s disease, Alzheimer’s ...